Thermo Fisher boosts sequencing business with $13.6B Life Tech buy

Thermo Fisher Scientific agreed to acquire Life Technologies, a maker of laboratory equipment for the life sciences, for $13.6 billion. The acquisition, which is expected to be finalized early next year, would make Thermo Fisher a major player in the next-generation gene sequencing market. The deal also improves "all three elements of our growth strategy: technological innovation, a unique customer value proposition, and expansion in emerging markets," Thermo Fisher President and CEO Marc Casper said.

View Full Article in:

GenomeWeb Daily News (free registration) · American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL